List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Vaccine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Varicella
1.4.3 Influenza
1.4.4 Polio
1.4.5 Hepatitis A
1.4.6 Rabies
1.4.7 BCG
1.4.8 Hepatitis B
1.4.9 Pertussis, Diphtheria, Tetanus
1.4.10 Pneumococcal
1.5 Market by Application
1.5.1 Global Human Vaccine Market Share by Application: 2022-2027
1.5.2 Adults
1.5.3 Children
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Human Vaccine Market
1.8.1 Global Human Vaccine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Human Vaccine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Human Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Human Vaccine Sales Volume Market Share by Region (2016-2021)
3.2 Global Human Vaccine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Human Vaccine Sales Volume
3.3.1 North America Human Vaccine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Human Vaccine Sales Volume
3.4.1 East Asia Human Vaccine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Human Vaccine Sales Volume (2016-2021)
3.5.1 Europe Human Vaccine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Human Vaccine Sales Volume (2016-2021)
3.6.1 South Asia Human Vaccine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Human Vaccine Sales Volume (2016-2021)
3.7.1 Southeast Asia Human Vaccine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Human Vaccine Sales Volume (2016-2021)
3.8.1 Middle East Human Vaccine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Human Vaccine Sales Volume (2016-2021)
3.9.1 Africa Human Vaccine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Human Vaccine Sales Volume (2016-2021)
3.10.1 Oceania Human Vaccine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Human Vaccine Sales Volume (2016-2021)
3.11.1 South America Human Vaccine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Human Vaccine Sales Volume (2016-2021)
3.12.1 Rest of the World Human Vaccine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Human Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Human Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Human Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Human Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Human Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Human Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Human Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Human Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Human Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Human Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Human Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Human Vaccine Sales Volume Market Share by Type (2016-2021)
14.2 Global Human Vaccine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Human Vaccine Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Human Vaccine Consumption Volume by Application (2016-2021)
15.2 Global Human Vaccine Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Human Vaccine Business
16.1 CNBG
16.1.1 CNBG Company Profile
16.1.2 CNBG Human Vaccine Product Specification
16.1.3 CNBG Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Changsheng Life
16.2.1 Changsheng Life Company Profile
16.2.2 Changsheng Life Human Vaccine Product Specification
16.2.3 Changsheng Life Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Zhifei
16.3.1 Zhifei Company Profile
16.3.2 Zhifei Human Vaccine Product Specification
16.3.3 Zhifei Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 ChengDa Bio
16.4.1 ChengDa Bio Company Profile
16.4.2 ChengDa Bio Human Vaccine Product Specification
16.4.3 ChengDa Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Kangtai
16.5.1 Kangtai Company Profile
16.5.2 Kangtai Human Vaccine Product Specification
16.5.3 Kangtai Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 SINOVAC BIOTECH
16.6.1 SINOVAC BIOTECH Company Profile
16.6.2 SINOVAC BIOTECH Human Vaccine Product Specification
16.6.3 SINOVAC BIOTECH Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Hissen
16.7.1 Hissen Company Profile
16.7.2 Hissen Human Vaccine Product Specification
16.7.3 Hissen Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Walvax Biotechnology
16.8.1 Walvax Biotechnology Company Profile
16.8.2 Walvax Biotechnology Human Vaccine Product Specification
16.8.3 Walvax Biotechnology Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 GSK
16.9.1 GSK Company Profile
16.9.2 GSK Human Vaccine Product Specification
16.9.3 GSK Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 SANOFI
16.10.1 SANOFI Company Profile
16.10.2 SANOFI Human Vaccine Product Specification
16.10.3 SANOFI Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Rong An
16.11.1 Rong An Company Profile
16.11.2 Rong An Human Vaccine Product Specification
16.11.3 Rong An Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 NuoCheng Bio
16.12.1 NuoCheng Bio Company Profile
16.12.2 NuoCheng Bio Human Vaccine Product Specification
16.12.3 NuoCheng Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Hualan Bio
16.13.1 Hualan Bio Company Profile
16.13.2 Hualan Bio Human Vaccine Product Specification
16.13.3 Hualan Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Tiantan biological
16.14.1 Tiantan biological Company Profile
16.14.2 Tiantan biological Human Vaccine Product Specification
16.14.3 Tiantan biological Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Changchun Baike
16.15.1 Changchun Baike Company Profile
16.15.2 Changchun Baike Human Vaccine Product Specification
16.15.3 Changchun Baike Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Adimmune
16.16.1 Adimmune Company Profile
16.16.2 Adimmune Human Vaccine Product Specification
16.16.3 Adimmune Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Zhongyianke Biotech
16.17.1 Zhongyianke Biotech Company Profile
16.17.2 Zhongyianke Biotech Human Vaccine Product Specification
16.17.3 Zhongyianke Biotech Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Human Vaccine Manufacturing Cost Analysis
17.1 Human Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Human Vaccine
17.4 Human Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Human Vaccine Distributors List
18.3 Human Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Human Vaccine (2022-2027)
20.2 Global Forecasted Revenue of Human Vaccine (2022-2027)
20.3 Global Forecasted Price of Human Vaccine (2016-2027)
20.4 Global Forecasted Production of Human Vaccine by Region (2022-2027)
20.4.1 North America Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.9 South America Human Vaccine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Human Vaccine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Human Vaccine by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Human Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Human Vaccine by Country
21.3 Europe Market Forecasted Consumption of Human Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Human Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Human Vaccine by Country
21.6 Middle East Forecasted Consumption of Human Vaccine by Country
21.7 Africa Forecasted Consumption of Human Vaccine by Country
21.8 Oceania Forecasted Consumption of Human Vaccine by Country
21.9 South America Forecasted Consumption of Human Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Human Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
